drugset / Trial / NCT05584631
IVIG vs SCIG in CIDP
Non-randomizedCrossoverOpen-labelOther
Summary
Current dosing practices for immunoglobulin G (IgG) may be inadequate in extreme body weight. The current study will evaluate the influence of body composition on intravenous and subcutaneous administration of immunoglobulin G in patients.
Timeline
- Start
- 2022-09-11
- Primary completion
- 2026-12-01
- Completion
- 2026-12-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | immune globulin G | Protein / enzyme biologic | — | Intravenous |
| Subject | immune globulin G | Protein / enzyme biologic | — | Subcutaneous |